1.01
-0.04 (-3.81%)
-0.04 (-3.81%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 565,556 |
|
|||||
| News | - | ||||||
| Day High | 1.0599 | Low High |
|||||
| Day Low | 1.01 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.04 | -3.81% | 1.01 | 19:45:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.05 | 1.01 | 1.0599 | 1.01 | 1.05 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,845 | 565,556 | $ 1.03 | $ 582,980 | - | 1.01 - 3.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:42:56 | 1 | $ 1.02 | USD |
Period:
Draw Mode:
Hepion Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 76.99M | 76.23M | 76.12M | $ - | $ - | -2.23 | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 1.00% |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.1749 | 1.01 | 1.09 | 566,489 | -0.14 | -12.17% |
| 1 Month | 1.31 | 1.33 | 1.01 | 1.18 | 671,842 | -0.30 | -22.9% |
| 3 Months | 1.44 | 1.59 | 1.01 | 1.28 | 760,606 | -0.43 | -29.86% |
| 6 Months | 1.61 | 1.85 | 1.01 | 1.48 | 1,001,458 | -0.60 | -37.27% |
| 1 Year | 2.30 | 3.18 | 1.01 | 1.98 | 2,680,392 | -1.29 | -56.09% |
| 3 Years | 3.11 | 8.35 | 1.00 | 2.50 | 1,752,101 | -2.10 | -67.52% |
| 5 Years | 3.11 | 8.35 | 1.00 | 2.50 | 1,752,101 | -2.10 | -67.52% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, CRV431, is being developed to offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. |